Prismic AI

Prismic AI is a healthcare technology company that leverages generative artificial intelligence to optimize the clinical trial lifecycle. The company's platform is designed to assist pharmaceutical sponsors and contract research organizations (CROs) in automating trial feasibility, site selection, and patient recruitment workflows. By analyzing large-scale clinical datasets and real-world evidence, Prismic AI provides predictive insights that help reduce the time and cost associated with drug development. Their technology focuses on transforming unstructured data into actionable intelligence, allowing for more precise protocol design and operational efficiency. Headquartered in San Francisco, the company is part of the Y Combinator W24 cohort and aims to modernize the traditional clinical research infrastructure. Prismic AI's solutions are built to handle the complexities of modern clinical trials, ensuring that life-saving therapies reach patients faster.